Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer

BACKGROUND: A considerable number of patients with stage II/III colorectal cancer (CRC) will relapse within 5 years after surgery, which is a leading cause of death in early-stage CRC. The current TNM stage system is limited due to the heterogeneous clinical outcomes displayed in patients of same st...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zaoqu, Lu, Taoyuan, Li, Jing, Wang, Libo, Xu, Kaihao, Dang, Qin, Liu, Long, Guo, Chunguang, Jiao, Dechao, Sun, Zhenqiang, Han, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358813/
https://www.ncbi.nlm.nih.gov/pubmed/34394098
http://dx.doi.org/10.3389/fimmu.2021.702594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358813/
https://www.ncbi.nlm.nih.gov/pubmed/34394098
http://dx.doi.org/10.3389/fimmu.2021.702594

Ejemplares similares